Xu Aizhang, Freywald Andrew, Xie Yufeng, Li Zejun, Xiang Jim
Cancer Research Cluster, Saskatchewan Cancer Agency.
Department of Oncology.
Immunotargets Ther. 2017 Jun 15;6:39-49. doi: 10.2147/ITT.S131662. eCollection 2017.
Whether inflation of CD8 memory T (mT) cells, which is often derived from repeated prime-boost vaccinations or chronic viral infections in the elderly, would affect late CD8 T-cell immunity is a long-standing paradox. We have previously established an animal model with mT-cell inflation by transferring ConA-stimulated monoclonal CD8 T cells derived from Ova-specific T-cell-receptor transgenic OTI mice into irradiation-induced lymphopenic B6 mice. In this study, we also established another two animal models with mT-cell inflation by transferring, 1) ConA-stimulated monoclonal CD8 T cells derived from lymphocytic choriomeningitis virus glycoprotein-specific T-cell-receptor transgenic P14 mice, and 2) ConA-stimulated polyclonal CD8 T cells derived from B6.1 mice into B6 mice with irradiation-induced lymphopenia. We vaccinated these mice with recombinant Ova-expressing and Ova-pulsed dendritic cells, which stimulated CD4 T cell-independent and CD4 T-cell-dependent CD8 T-cell responses, respectively, and assessed Ova-specific CD8 T-cell responses by flow cytometry. We found that Ova-specific CD8 T-cell responses derived from the latter but not the former vaccination were significantly reduced in mice with CD8 mT-cell inflation compared to wild-type B6 mice. We determined that naïve CD8 T cells purified from splenocytes of mice with mT-cell inflation had defects in cell proliferation upon stimulation in vitro and in vivo and upregulated T-cell anergy-associated Itch and GRAIL molecules. Taken together, our data reveal that CD8 mT-cell inflation renders compromised CD4 T-cell-dependent CD8 T-cell immunity via naïve T-cell anergy, and thus show promise for the design of efficient vaccines for elderly patients with CD8 mT-cell inflation.
CD8记忆T(mT)细胞的扩增,通常源于老年人反复的初免-加强疫苗接种或慢性病毒感染,是否会影响晚期CD8 T细胞免疫,这是一个长期存在的矛盾问题。我们之前通过将源自卵清蛋白(Ova)特异性T细胞受体转基因OTI小鼠的伴刀豆球蛋白A(ConA)刺激的单克隆CD8 T细胞转移到经辐射诱导淋巴细胞减少的B6小鼠中,建立了一个mT细胞扩增的动物模型。在本研究中,我们还通过以下方式建立了另外两个mT细胞扩增的动物模型:1)将源自淋巴细胞性脉络丛脑膜炎病毒糖蛋白特异性T细胞受体转基因P14小鼠的ConA刺激的单克隆CD8 T细胞,以及2)将源自B6.1小鼠的ConA刺激的多克隆CD8 T细胞转移到经辐射诱导淋巴细胞减少的B6小鼠中。我们用表达重组Ova和Ova脉冲树突状细胞对这些小鼠进行疫苗接种,它们分别刺激不依赖CD4 T细胞和依赖CD4 T细胞的CD8 T细胞反应,并通过流式细胞术评估Ova特异性CD8 T细胞反应。我们发现,与野生型B6小鼠相比,在具有CD8 mT细胞扩增的小鼠中,源自后一种而非前一种疫苗接种的Ova特异性CD8 T细胞反应显著降低。我们确定,从具有mT细胞扩增的小鼠脾细胞中纯化的初始CD8 T细胞在体外和体内刺激后细胞增殖存在缺陷,并且上调了与T细胞无反应性相关的Itch和GRAIL分子。综上所述,我们的数据表明,CD8 mT细胞扩增通过初始T细胞无反应性导致依赖CD4 T细胞的CD8 T细胞免疫受损,因此为设计针对具有CD8 mT细胞扩增的老年患者的高效疫苗提供了希望。